Delivery Order SPE2DB20D2002-SPE2DB24FL66M

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order valued at $5,426.90 with an ultimate completion date of June 7, 2024. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of HIBICLENS 4% LIQUID 946ML, a medical product, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FL6E2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,143.44 for the supply of HIBICLENS 4% LIQUID 118ML, a medical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,959.10 for the supply of 4566188099 - Chlorhexidine 0.12% 15 ML CUP UD 15ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of October 24, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen has an Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) is a Delivery Order (SPE2DB20D2014|SPE2DB25FA19M) valued at $4,921.97 from the Defense Logistics Agency (DLA) for the supply of 4566205492 - Chlorhexidine 0.12% 15 ML CUP UD 15ML. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Chlorhexidine 0.12% 15 ML CUP UD 15ML, a medical product, with a ceiling value of $6,989.79. The contract is a firm fixed price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $1,129.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,023.11 firm-fixed-price delivery order, with a completion date of September 18, 2023, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen by the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $8,716.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $14,674.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $1,026.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL66M
    Delivery Order

This federal contract award, valued at $8,372.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HIBICLENS 4% LIQUID 946ML, a medical product, and has an ultimate completion date of July 10, 2024.

The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was open competition.

Generated 5/17/25, 9:50 AM